A total of 4 groups of NSG mice (7 mice/group) received a subcutaneous injection of the non-targeting control, Smad3 and Smad4 CRISPR KOs, generated in the A375m melanoma cell line (Figure 4a). The gene discussed is SMAD3; the disease is melanoma.